Betta Pharmaceuticals (China) Today
| 300558 Stock | 51.62 1.02 2.02% |
Performance13 of 100
| Odds Of DistressLess than 15
|
Betta Pharmaceuticals is trading at 51.62 as of the 27th of November 2024, a 2.02 percent increase since the beginning of the trading day. The stock's open price was 50.6. Betta Pharmaceuticals has less than a 15 % chance of experiencing some financial distress in the next two years of operation and had a good performance during the last 90 days. Equity ratings for Betta Pharmaceuticals Co are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of October 2024 and ending today, the 27th of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Betta Pharmaceuticals is entity of China. It is traded as Stock on SHE exchange. The company has 418.49 M outstanding shares. More on Betta Pharmaceuticals Co
Moving together with Betta Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Betta Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Betta Pharmaceuticals' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Betta Pharmaceuticals or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman Founder | Lieming Ding | ||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care (View all Sectors) | ||||
Betta Pharmaceuticals' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Betta Pharmaceuticals' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsBetta Pharmaceuticals can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Betta Pharmaceuticals' financial leverage. It provides some insight into what part of Betta Pharmaceuticals' total assets is financed by creditors.
| |||||
Betta Pharmaceuticals Co (300558) is traded on Shenzhen Stock Exchange in China and employs 15 people. Betta Pharmaceuticals is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 21.76 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Betta Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Betta Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Betta Pharmaceuticals operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 418.49 M outstanding shares.
Betta Pharmaceuticals generates positive cash flow from operations, but has no cash available
Check Betta Pharmaceuticals Probability Of Bankruptcy
Ownership AllocationBetta Pharmaceuticals retains a total of 418.49 Million outstanding shares. Betta Pharmaceuticals Co retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
Check Betta Ownership Details
Betta Pharmaceuticals Risk Profiles
Although Betta Pharmaceuticals' alpha and beta are two of the key measurements used to evaluate Betta Pharmaceuticals' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.04 | |||
| Semi Deviation | 3.14 | |||
| Standard Deviation | 4.39 | |||
| Variance | 19.27 |
Betta Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Betta Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Competition Analyzer Now
Competition AnalyzerAnalyze and compare many basic indicators for a group of related or unrelated entities |
| All Next | Launch Module |
Betta Pharmaceuticals Corporate Executives
Elected by the shareholders, the Betta Pharmaceuticals' board of directors comprises two types of representatives: Betta Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Betta. The board's role is to monitor Betta Pharmaceuticals' management team and ensure that shareholders' interests are well served. Betta Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Betta Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jianxun Fan | CFO VP | Profile |
Other Information on Investing in Betta Stock
Betta Pharmaceuticals financial ratios help investors to determine whether Betta Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Betta with respect to the benefits of owning Betta Pharmaceuticals security.